Skip to Content

WATSON 822 (Naproxen 375 mg)

Pill imprint WATSON 822 has been identified as Naproxen 375 mg.

Naproxen is used in the treatment of back pain; sciatica; gout, acute; ankylosing spondylitis; muscle pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy. Naproxen 375 mg is not a controlled substance under the Controlled Substance Act (CSA).

Naproxen 375 mg WATSON 822
Discount Card Promo
Naproxen
Imprint:
WATSON 822
Strength:
375 mg
Color:
Gray
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-0822
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
povidone
synthetic ferric oxide black
synthetic ferric oxide red
synthetic ferric oxide yellow

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide